Literature DB >> 12496217

Biodefense-driven murine model of pneumonic melioidosis.

J A Jeddeloh1, D L Fritz, D M Waag, J M Hartings, G P Andrews.   

Abstract

A whole-body mouse model of pneumonic melioidosis was established for future evaluation of biodefense vaccine candidates. The aerosol 50% lethal doses of Burkholderia pseudomallei strain 1026b for BALB/c and C57BL/6 mice and the times to death, dissemination in organs, and tissue loads after exposure of the mice to low- and high-dose aerosols are reported. In addition, rpsL mutant backgrounds were attenuated in this acute model of disease.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12496217      PMCID： PMC143420          DOI： 10.1128/IAI.71.1.584-587.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

Review 1.  Current studies on the pathogenesis of melioidosis.

Authors:  D E Woods; D DeShazer; R A Moore; P J Brett; M N Burtnick; S L Reckseidler; M D Senkiw
Journal:  Microbes Infect       Date:  1999-02       Impact factor: 2.700

2.  In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test.

Authors:  H S Heine; M J England; D M Waag; W R Byrne
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Enhancement of virulence of Malleomyces pseudomallei.

Authors:  C NIGG; J RUCH; E SCOTT; K NOBLE
Journal:  J Bacteriol       Date:  1956-05       Impact factor: 3.490

4.  Measurement of the respiratory volumes of laboratory animals.

Authors:  A C GUYTON
Journal:  Am J Physiol       Date:  1947-07-01

5.  Novel ribosomal mutations affecting translational accuracy, antibiotic resistance and virulence of Salmonella typhimurium.

Authors:  J Björkman; P Samuelsson; D I Andersson; D Hughes
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

6.  Characterization of a murine model of melioidosis: comparison of different strains of mice.

Authors:  I Hoppe; B Brenneke; M Rohde; A Kreft; S Häussler; A Reganzerowski; I Steinmetz
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

7.  Induction of multiple chemokine and colony-stimulating factor genes in experimental Burkholderia pseudomallei infection.

Authors:  J L Barnes; G C Ulett; N Ketheesan; T Clair; P M Summers; R G Hirst
Journal:  Immunol Cell Biol       Date:  2001-10       Impact factor: 5.126

8.  Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei.

Authors:  R A Moore; D DeShazer; S Reckseidler; A Weissman; D E Woods
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

9.  Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir.

Authors:  Mike Bray; Mark Martinez; Deborah Kefauver; Michael West; Chad Roy
Journal:  Antiviral Res       Date:  2002-06       Impact factor: 5.970

10.  Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei.

Authors:  P Santanirand; V S Harley; D A Dance; B S Drasar; G J Bancroft
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441
View more
  54 in total

1.  Type III secretion: a virulence factor delivery system essential for the pathogenicity of Burkholderia mallei.

Authors:  Ricky L Ulrich; David DeShazer
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

2.  Natural history of inhalation melioidosis in rhesus macaques (Macaca mulatta) and African green monkeys (Chlorocebus aethiops).

Authors:  John J Yeager; Paul Facemire; Paul A Dabisch; Camenzind G Robinson; David Nyakiti; Katie Beck; Reese Baker; M Louise M Pitt
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

3.  A type IV pilin, PilA, Contributes To Adherence of Burkholderia pseudomallei and virulence in vivo.

Authors:  Angela E Essex-Lopresti; Justin A Boddey; Richard Thomas; Martin P Smith; M Gill Hartley; Timothy Atkins; Nat F Brown; Chuk Hai Tsang; Ian R A Peak; Jim Hill; Ifor R Beacham; Richard W Titball
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Pathological findings and diagnostic implications of a rhesus macaque (Macacca mulatta) model of aerosol exposure to Burkholderia mallei (glanders).

Authors:  Samuel L Yingst; Paul Facemire; Lara Chuvala; David Norwood; Mark Wolcott; Louis Huzella
Journal:  J Med Microbiol       Date:  2015-04-07       Impact factor: 2.472

5.  Virulence of Burkholderia mallei quorum-sensing mutants.

Authors:  Charlotte Majerczyk; Loren Kinman; Tony Han; Richard Bunt; E Peter Greenberg
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

6.  Genetic tools for select-agent-compliant manipulation of Burkholderia pseudomallei.

Authors:  Kyoung-Hee Choi; Takehiko Mima; Yveth Casart; Drew Rholl; Ayush Kumar; Ifor R Beacham; Herbert P Schweizer
Journal:  Appl Environ Microbiol       Date:  2007-12-21       Impact factor: 4.792

7.  Pathogenesis of percutaneous infection of goats with Burkholderia pseudomallei: clinical, pathologic, and immunological responses in chronic melioidosis.

Authors:  Carl Soffler; Angela M Bosco-Lauth; Tawfik A Aboellail; Angela J Marolf; Richard A Bowen
Journal:  Int J Exp Pathol       Date:  2014-02-27       Impact factor: 1.925

8.  Octanoyl-homoserine lactone is the cognate signal for Burkholderia mallei BmaR1-BmaI1 quorum sensing.

Authors:  Breck A Duerkop; Ricky L Ulrich; E Peter Greenberg
Journal:  J Bacteriol       Date:  2007-05-11       Impact factor: 3.490

9.  Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.

Authors:  Surasakdi Wongratanacheewin; Wannapa Kespichayawattana; Pakamas Intachote; Sathit Pichyangkul; Rasana W Sermswan; Arthur M Krieg; Stitaya Sirisinha
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.

Authors:  W Joost Wiersinga; Thierry Calandra; Liesbeth M Kager; Gerritje J W van der Windt; Thierry Roger; Didier le Roy; Sandrine Florquin; Sharon J Peacock; Fred C G J Sweep; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.